New and improved classifiers may sharpen thyroid nodule diagnosisJanuary 3, 2018Head & Neck/Thyroid Cancers
ASCO larynx-preservation guidelines reflect important practice changesDecember 4, 2017Head & Neck/Thyroid Cancers
Cancer patients with TKI-induced hypothyroidism had better survival ratesNovember 15, 2017Patient & Survivor CareGastroenterologyLeukemia, Myelodysplasia, TransplantationLung CancerRenal Cell CarcinomaHead & Neck/Thyroid CancersBreast Cancer
Papillary thyroid microcarcinoma: Is ‘less is more’ the right approach?October 21, 2017Head & Neck/Thyroid Cancers
Keynote 040: Pembrolizumab misses efficacy endpoint in advanced HNSCCOctober 17, 2017Immuno-oncologyHead & Neck/Thyroid Cancers
Liquid biopsy predicts checkpoint inhibitor responseOctober 2, 2017Immuno-oncologyLung CancerMelanomaHead & Neck/Thyroid Cancers
Calcitonin-to-CEA ratio predicts medullary thyroid cancer survivalSeptember 19, 2017Head & Neck/Thyroid Cancers
AML risk is doubled in low-risk thyroid cancer patients unnecessarily given radioactive iodine therapySeptember 18, 2017Head & Neck/Thyroid Cancers
Pembrolizumab, nivolumab linked to 3% rate of neurologic eventsSeptember 5, 2017Immuno-oncologyPatient & Survivor CareMelanomaLung CancerRenal Cell CarcinomaHead & Neck/Thyroid CancersNeuro-oncology
Contralateral nodal thyroid metastases show slow progressionAugust 10, 2017Head & Neck/Thyroid Cancers
VIDEO: Lenvatinib’s real-world thyroid cancer performance matches trialAugust 8, 2017Head & Neck/Thyroid Cancers
Thyroid-nodule size boosts serum thyroglobulin’s diagnostic valueJuly 31, 2017Head & Neck/Thyroid Cancers
